Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure
Scheduled RTX maintenance therapy effectively maintained remission in children with multi-target therapy-refractory NS, allowing substantial reduction or cessation of steroids and other immunosuppressants.
Authors
- Liru Qiu (ORCID: https://orcid.org/0000-0002-1583-7183)
- Jianhua Zhou (ORCID: https://orcid.org/0000-0003-2096-8126)
- Jing Yang (ORCID: https://orcid.org/0000-0002-3833-9996)
- PU Jin-yun (ORCID: https://orcid.org/0000-0001-9089-1094)
- Yonghua He (ORCID: https://orcid.org/0009-0002-2655-4899)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-4249-6089)
Institutions
- Wuhan Children's Hospital (CN)
Publication Details
- Journal
- Pediatric Nephrology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1007/s00467-025-07069-6
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00